The Effects of Novel and Newly Approved Antipsychotics on Serum Prolactin Levels: A Comprehensive Review.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 421, doi. 10.1007/s40263-014-0157-3
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2014 AND VI 28 AND IP 5
Results: 8
1
2
Adenosine A Receptor Antagonists in Parkinson's Disease: Progress in Clinical Trials from the Newly Approved Istradefylline to Drugs in Early Development and Those Already Discontinued.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 455, doi. 10.1007/s40263-014-0161-7
- By:
- Publication type:
- Article
3
Adenosine A2A receptor antagonists in Parkinson's disease: progress in clinical trials from the newly approved istradefylline to drugs in early development and those already discontinued.
- Published in:
- 2014
- By:
- Publication type:
- journal article
4
Birth Outcomes in Newborns Fathered by Men with Multiple Sclerosis Exposed to Disease-Modifying Drugs.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 475, doi. 10.1007/s40263-014-0154-6
- By:
- Publication type:
- Article
5
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 389, doi. 10.1007/s40263-014-0156-4
- By:
- Publication type:
- Article
6
Inpatient Management of Acute Alcohol Withdrawal Syndrome.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 401, doi. 10.1007/s40263-014-0163-5
- By:
- Publication type:
- Article
7
A Cross-Sectional Study on Drug Use in Multiple System Atrophy.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 483, doi. 10.1007/s40263-014-0159-1
- By:
- Publication type:
- Article
8
Cognitive Effects of Statin Medications.
- Published in:
- CNS Drugs, 2014, v. 28, n. 5, p. 411, doi. 10.1007/s40263-014-0147-5
- By:
- Publication type:
- Article